{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:51:01Z","timestamp":1777045861487,"version":"3.51.4"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.2169\/internalmedicine.9702-22","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T22:11:14Z","timestamp":1669155074000},"page":"365-371","source":"Crossref","is-referenced-by-count":7,"title":["Actual Telemedicine Needs of Japanese Patients with Neurological Disorders in the COVID-19 Pandemic"],"prefix":"10.2169","volume":"62","author":[{"given":"Ryo","family":"Sasaki","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taijun","family":"Yunoki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Morihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kwon S, Joshi AD, Lo CH, et al. Association of social distancing and face mask use with risk of COVID-19. Nat Commun 12: 3737, 2021.","DOI":"10.1038\/s41467-021-24115-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of telehealth during the COVID-19 pandemic: scoping review. J Med Internet Res 22: e24087, 2020.","DOI":"10.2196\/24087"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Klein BC, Busis NA. COVID-19 is catalyzing the adoption of teleneurology. Neurology 94: 903-904, 2020.","DOI":"10.1212\/WNL.0000000000009494"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Duncan PW, Bernhardt J. Telerehabilitation: has its time come? Stroke 52: 2694-2696, 2021.","DOI":"10.1161\/STROKEAHA.121.033289"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Huang JF, Greenway MRF, Nasr DM, et al. Telestroke in the time of COVID-19: the Mayo Clinic experience. Mayo Clin Proc 95: 1704-1708, 2020.","DOI":"10.1016\/j.mayocp.2020.06.007"},{"key":"6","unstructured":"6. Sakurai K, Suzuki Y, Hasegawa Y. Awareness of telemedicine among patients with neurological disorders. Neurol Ther 36: 606-610, 2019."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Akiyama H, Hasegawa Y. A trial case of medical treatment for primary headache using telemedicine. Medicine (Baltimore) 97: e9891, 2018.","DOI":"10.1097\/MD.0000000000009891"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grazzi L, Rizzoli P. Lessons from lockdown - behavioural interventions in migraine. Nat Rev Neurol 17: 195-196, 2021.","DOI":"10.1038\/s41582-021-00475-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Detke HC, Goadsby PJ, Wang S, et al. Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology 91: e2211-e2221, 2018.","DOI":"10.1212\/WNL.0000000000006640"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Silberstein SD, Dodick DW, Bigal ME, et al. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med 377: 2113-2122, 2017.","DOI":"10.1056\/NEJMoa1709038"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kubota T, Kuroda N, Horinouchi T, et al. Barriers to telemedicine among physicians in epilepsy care during the COVID-19 pandemic: a national-level cross-sectional survey in Japan. Epilepsy Behav 126: 108487, 2022.","DOI":"10.1016\/j.yebeh.2021.108487"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol 75: 279-286, 2018.","DOI":"10.1001\/jamaneurol.2017.3949"},{"key":"13","unstructured":"13. Crowley BZ, Patrie J, Sperling SA. Depression differentially affects patient and caregiver perceptions of neuropsychiatric symptoms in Parkinson&apos;s disease. Clin Neuropsychol. Forthcoming."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sperens M, Georgiev D, Eriksson Domell\u00f6f M, et al. Activities of daily living in Parkinson&apos;s disease: time\/gender perspective. Acta Neurol Scand 141: 168-176, 2020.","DOI":"10.1111\/ane.13189"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fujita T, Babazono A, Kim SA, Jamal A, Li Y. Effects of physician visit frequency for Parkinson&apos;s disease treatment on mortality, hospitalization, and costs: a retrospective cohort study. BMC Geriatr 21: 707, 2021.","DOI":"10.1186\/s12877-021-02685-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Grabowski DC, Mor V. Nursing home care in crisis in the wake of COVID-19. JAMA 324: 23-24, 2020.","DOI":"10.1001\/jama.2020.8524"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Manca R, De Marco M, Venneri A. The impact of COVID-19 infection and enforced prolonged social isolation on neuropsychiatric symptoms in older adults with and without dementia: a review. Front Psychiatry 11: 585540, 2020.","DOI":"10.3389\/fpsyt.2020.585540"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/3\/62_9702-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:30:32Z","timestamp":1675481432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/3\/62_9702-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9702-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"9702-22"}}